On June 19th, the three-day CPHI (World Pharmaceutical Raw Materials China Exhibition) opened in Shanghai, China. A.H.A International and Huayi Pharmaceutical jointly participated in the exhibition, showcasing W2P02.
The Chinese pharmaceutical industry plays an important role in the global pharmaceutical industry value chain. As a leading international trade enterprise in the pharmaceutical industry, A.H.A International and Huayi Pharmaceutical have attracted numerous domestic and foreign customers and partners to come to the exhibition booth for negotiation with their dual wing development model of characteristic international trade and high-end pharmaceutical research and manufacturing.
This exhibition was led by Liang Qing, Chairman of A.H.A International Co., Ltd, and a team led by Gao Yu, Chairman of Huayi Pharmaceutical, Yu Lingmin, Vice President of A.H.A International, Jiang Yelong, Vice President and General Manager of Food Ingredients Division, Wang Yunfeng, Vice President, Wang Qizhuang, Assistant President and General Manager of Pharmaceutical Division, and Li Yuanyuan, General Manager of Nutrition and Health Division, participated in discussions on products and services that interested customers.
The field of big health is one of the characteristic international trade businesses of A.H.A International Co., Ltd. After years of exploration and deep cultivation, an industrial chain development model mainly consisting of pharmaceutical products, nutrition products, and food ingredients has gradually formed, among which pharmaceutical products are an important component in the field of big health. A.H.A International Co., Ltd hopes to discuss the future development of pharmaceutical trade with CDMO business partners, manufacturers, and distributors from both domestic and international sources, promote the transformation of the medical model pharmaceutical trade, and build a reputation for integrated pharmaceutical trade services.
AHA International Co., Ltd tiene más de 40 años de experiencia y recursos profesionales en comercio exterior, tiene múltiples calificaciones de franquicia y ha aprobado múltiples certificaciones internacionales como AEO, ISO, Ecovadis, etc. Confiando en un equipo comercial profesional, nuestro objetivo es crear uno -Detener soluciones de comercio exterior como "marketing, soporte regulatorio, operaciones comerciales, soporte logístico y servicio postventa". A través de la acumulación continua de recursos profesionales y experiencia en investigación y desarrollo, producción y registro, exploramos continuamente la posibilidad de brindar soluciones de operación de CDMO farmacéuticas integradas, profesionales y confiables para fabricantes, distribuidores y socios nacionales y extranjeros. El ámbito comercial de la empresa cubre casi 100 países y regiones, con casi 1.000 proveedores cooperativos, que operan cerca de 1.000 tipos de productos y una exportación anual promedio de más de 4.000 contenedores estándar. Establecer empresas operativas en el extranjero en áreas comerciales clave para brindar a los clientes servicios de almacenamiento y localización.